Preclinical comparison of four [
Fluorine-18
PSMA
Prostate cancer
Radiohybrid
Journal
EJNMMI research
ISSN: 2191-219X
Titre abrégé: EJNMMI Res
Pays: Germany
ID NLM: 101560946
Informations de publication
Date de publication:
07 Dec 2020
07 Dec 2020
Historique:
received:
09
09
2020
accepted:
24
11
2020
entrez:
7
12
2020
pubmed:
8
12
2020
medline:
8
12
2020
Statut:
epublish
Résumé
Radiohybrid (rh) ligands, a novel class of prostate-specific membrane antigen (PSMA)-targeted radiopharmaceuticals, can be labeled either with [ Since [ A synthetic protocol for enantiopure [ Cell studies revealed high PSMA affinity and internalization for [ [
Identifiants
pubmed: 33284394
doi: 10.1186/s13550-020-00740-z
pii: 10.1186/s13550-020-00740-z
pmc: PMC7721954
doi:
Types de publication
Journal Article
Langues
eng
Pagination
149Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : Sonderforschungsbereich 824, B11, Z
Références
J Nucl Med. 2020 May;61(5):702-709
pubmed: 31836686
Molecules. 2020 May 14;25(10):
pubmed: 32423178
J Nucl Med. 2017 May;58(5):687-688
pubmed: 28408526
J Urol. 2018 Jan;199(1):126-132
pubmed: 28736318
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):678-688
pubmed: 27889802
J Pharm Sci. 2003 Nov;92(11):2236-48
pubmed: 14603509
Eur Urol. 2016 Dec;70(6):926-937
pubmed: 27363387
Lancet Oncol. 2018 Dec;19(12):e696-e708
pubmed: 30507436
J Nucl Med. 2015 May;56(5):668-74
pubmed: 25791990
Appl Radiat Isot. 2013 Jun;76:55-62
pubmed: 23063597
J Org Chem. 1997 Jun 27;62(13):4307-4312
pubmed: 11671751
Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):486-95
pubmed: 23179945
Angew Chem Int Ed Engl. 2006 Sep 11;45(36):6047-50
pubmed: 16888726
J Nucl Med. 2020 May;61(5):710-715
pubmed: 31836681
Lancet. 2020 Apr 11;395(10231):1208-1216
pubmed: 32209449
J Nucl Med. 2020 May;61(5):696-701
pubmed: 31836682
Biochem Pharmacol. 2002 Nov 1;64(9):1355-74
pubmed: 12392818
J Nucl Med. 2017 Mar;58(3):425-431
pubmed: 27789722
Bioconjug Chem. 2012 Apr 18;23(4):688-97
pubmed: 22369515
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):197-209
pubmed: 25411132
Mol Pharm. 2006 May-Jun;3(3):198-211
pubmed: 16749853
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024
pubmed: 28283702
Theranostics. 2020 Jan 1;10(1):1-16
pubmed: 31903102
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1076-1077
pubmed: 29445927
Nat Rev Urol. 2019 Feb;16(2):71-72
pubmed: 30546132
Chemistry. 2009;15(9):2140-7
pubmed: 19156812
EJNMMI Res. 2018 Apr 12;8(1):30
pubmed: 29651565
Semin Nucl Med. 2015 Jan;45(1):58-65
pubmed: 25475379
Clin Cancer Res. 2011 Dec 15;17(24):7645-53
pubmed: 22042970
J Nucl Med. 2020 May;61(5):735-742
pubmed: 31862804
Nuklearmedizin. 2012;51(1):1-8
pubmed: 21989864
Mol Imaging Biol. 2015 Aug;17(4):575-84
pubmed: 26013479
EJNMMI Res. 2014 Dec;4(1):63
pubmed: 26116124